Bevacizumab Vor Allem Bei Hohem Risiko Sinnvoll
Info Onkologie
doi 10.1007/s15004-015-0991-6
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Springer Science and Business Media LLC
Available in full text
November 1, 2015
Springer Science and Business Media LLC